Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Rhone-Poulenc Overseas Limited Announces Redemption of All Outstanding Cumulative Guaranteed Preference Shares, Series A NEW YORK, Oct. 15 /PRNewswire-FirstCall/ -- Rhone-Poulenc Overseas...
Aventis Ships 30 Million Doses of Influenza Vaccine to Health-Care Providers Pre-Booked Customers Received Partial or Full Influenza Vaccine Order in September; Balance to be Shipped in...
Advisory Panel Recommends FDA Licensure of Aventis' Menactra(TM) Vaccine for Protection Against Meningococcal Disease - First Candidate Quadrivalent Conjugate Meningococcal Vaccine - SWIFTWATER...
Aventis Named to List of Top 100 Companies for Working Mothers Receives Honors Three Years Running BRIDGEWATER, N.J., Sept. 21 /PRNewswire-FirstCall/ -- For the third year in a row, Aventis has...
The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity PARIS, Sept. 16 /PRNewswire-FirstCall/ -- The sanofi-aventis Group launched an advertising...
Coley Pharmaceutical Group Receives Payment From Aventis for Clinical Milestone in Collaboration on Allergic Respiratory Diseases WELLESLEY, Mass., Sept. 14 /PRNewswire/ -- Coley Pharmaceutical...
FDA Approves Taxotere(R) for the Treatment of Women with Early Stage Breast Cancer Earlier use of Taxotere(R) shown to significantly improve disease-free survival by reducing the risk of relapse...
Aventis Submits Application for FDA Licensure of ADACEL(TM) Vaccine for Prevention of Tetanus, Diphtheria and Pertussis in Adolescents and Adults - Vaccine Leader Looks to Introduce Pertussis...
Ventiv Health Announces Sales and Marketing Agreement with Aventis Contract Calls for Over 450 Sales Representatives Focused on Primary Care and Specialist Markets SOMERSET, N.J., Aug. 5...
FDA Approves Sculptra(TM) (Injectable Poly-L-Lactic Acid) BERWYN, Penn., Aug. 3 /PRNewswire/ -- Dermik Laboratories, the US dermatology arm of Aventis (NYSE:AVE), announced today that the US...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
